Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
|
|
140 * !
|
Mon, 7/30/2018,
10:30 AM -
12:20 PM
|
CC-West 211
|
Design and Analysis of Cancer Immunotherapy Trials — Invited Papers
|
Biopharmaceutical Section, Society for Clinical Trials, Statistics in Biopharmaceutical Research Journal
|
Organizer(s): Zhenzhen Xu , FDA
|
Chair(s): Bifeng Ding, AbbVie
|
10:35 AM
|
A Bayesian Phase I/II Trial Design for Immunotherapy
Suyu Liu, MD Anderson Cancer Center; Beibei Guo, Louisiana State University; Ying Yuan, University of Texas M.D. Anderson Cancer Center
|
11:00 AM
|
Achieving Optimal Power of Logrank Test with Random Treatment Time-Lag Effect
Zhenzhen Xu , FDA; Yongsoek Park, Unversity of Pittsburgh; Boguang Zhen, FDA; Bin Zhu, NIH/NCI
|
11:25 AM
|
Use of Piecewise Weighted Log-Rank Test for Trials with Delayed Treatment Effect
Boguang Zhen, FDA; Zhenzhen Xu , FDA; Bin Zhu, NIH/NCI; Yongsoek Park, Unversity of Pittsburgh
|
11:50 AM
|
Practical Considerations on the Challenges to the Design and Analysis of Immuno-Oncology Trials
Yabing Mai, AbbVie, Inc; Yue Shentu, Merck and Co Inc
|
12:15 PM
|
Floor Discussion
|
|